Anti-inflammatory antibodies and uses therefor

Details for Australian Patent Application No. 2010328359 (hide)

Owner Decimmune Therapeutics, Inc.

Inventors Carroll, Elisabeth

Agent Spruson & Ferguson

Pub. Number AU-A-2010328359

PCT Pub. Number WO2011/071883

Priority 61/275,723 07.12.09 US

Filing date 7 December 2010

Wipo publication date 16 June 2011

International Classifications

C07K 16/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

21 June 2012 PCT application entered the National Phase

  PCT publication WO2011/071883 Priority application(s): WO2011/071883

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010328360-Chloride ingress-resistant concrete and articles formed therewith

2010328358-Method and apparatus for osmotic power generation